Efficacy and Safety of Rivaroxaban versus Warfarin for the Treatment of Acute Pulmonary Embolism: A Real-World Study

Table 7

Comparison of rivaroxaban and thrombolytic therapeutic in intermediate-high-risk patients.

		Thrombolysis (13)	Rivaroxaban (11)		value
Efficacy				-1.479	0.139
	Disappeared	6 (46.15%)	7 (63.64)	0.734	0.392
	Effective	6 (46.15%)	2 (18.18)	1.028	0.311
	No effect	0 (0.00%)	2 (18.18)		0.199
	Progressed	0 (0.00%)	0 (0.00)
	Reappeared	1 (7.69%)	0 (0.00)		0.542
Bleeding				2.517	0.113
	Bleeding	3 (23.08%)	5 (45.45%)	0.524	0.496
	Mild bleeding	10 (76.92%)	5 (45.45%)	1.354	0.245
	Serve bleeding	0 (0.00%)	0 (0.00%)
	Major bleeding	0 (0.00%)	0 (0.00%)
	Death	0 (0.00%)	2 (18.18%)		0.199